NCT03807479 - Study in Patients With Chronic Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

February 28, 2023

Study Completion Date

August 31, 2023

Conditions

Leukemia, Myeloid, Chronic-Phase

Interventions

DRUG

Ponatinib

2 film-coated tablets à 15mg for oral administration on a daily basis

Trial Locations (10)

Charité University Medicine Berlin - Medical Clinic, Department of Hematology, Oncology and Tumor Immunology, Berlin

University Medicine Greifswald, Clinic and Policlinic - Internal Medicine C - Hematology and Oncology, Greifswald

Asklepios Clinic St. Georg - Department of Oncology, Section Hematology, Hamburg

UKRUB University Hospital of Ruhr-University Bochum, Clinic for Hematology and Oncology, Minden

Clinic for Hematologie, Marburg

University Hospital Essen gGmbH, Westdeutsches Tumorzentrum; Internal Medicine (Tumor Research), Essen

University Hospital RWTH Aachen,Clinic for Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Department IV, Aachen

University Hospital Mannheim GmbH, III. Medical Clinic for Hematology and Oncology, Mannheim

University Hospital Ulm - Department for internal medicine III, Ulm

University Hospital, Halle